FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire Stock Sale/Buyback News
Enjoying Merger Arbitrage Limited?
Sign up then! It's quick and FREE
Have time to share an article? It's very much appreciated!!